However, the inhibition of VEGF activity via the p38 pathway could alleviate tamoxifen resistance [132], as p38 activity was elevated in xenografts of breast cancer cells that were resistant to tamoxifen [133]. This evidence concerns the gene MAPK1 and breast cancer.